PUBLIC CONTRACT · 2025
Aquisição de ETANERCEPT CANETA 50 MG/1 ML (BIOSSIMILAR) SOL INJ 1 ML SC - Ajuste Direto N.º 91050025
- Contract value
- €219,450.00
- Signed on
- 9 May 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11491105PUBLISHED DESCRIPTION
Aquisição de ETANERCEPT CANETA 50 MG/1 ML (BIOSSIMILAR) SOL INJ 1 ML SC para o ano de 2025 - Ajuste Direto N.º 91050025
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Biogen Portugal Sociedade Farmacêutica Unipessoal Lda. · Tax ID 506415740
Values and timeline
- Contract price
- €219,450.00
- Procedure base price
- €219,450.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 June 2025
- Award date
- 29 April 2025
- Signing date
- 9 May 2025
- Performance period
- 183 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7671521
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.